Use of levocetirizine and montelukast to ameliorate inflammation following radiation exposure
AssigneeIRR, Inc.
InventorBruce Chandler May
Life of this patent
Estimating the term…
Abstract
The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient. The combination can be useful during and following radiation exposure to ameliorate the inflammatory response.
Claims8
A method of treating a patient who has been exposed to radiation comprising administering to the patient an effective amount of a combination of levocetirizine and montelukast wherein the radiation exposure is associated with radiation therapy and wherein the combination ameliorates an inflammatory response associated with the radiation.
Dependencies are inferred from the claim text.